ArticlePloS one2025
Cysteine pattern barcoding-based dataset filtration enhances the machine learning-assisted interpretation of Conus venom peptide therapeutics.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crude cone snail venom is a rich source of bioactive compounds with significant therapeutic potential. In this study, we conducted a comprehensive analysis of 5,985 cone snail peptides across 82 Conus species to identify unique cysteine (Cys) patterns and associated frameworks. The classification of these Cys patterns, based on conserved framework combinations, enabled the generation of species-level pattern barcodes. These barcodes were then evaluated to assess the species correlations of individual sequences. By analyzing 151 known Conus peptide PDB files, we computed Cys disulfide linkages to assess overall stability profiles. Incorporating barcode data allowed us to filter the dataset and prepare it for machine learning (ML) processing. Random Forest (RF) modeling, a supervised learning technique, was used to predict the therapeutic potential of venom peptides. Feature extraction was based on known venom-derived approved peptide-based drugs. The dataset was split into a 70:30 train-test ratio. A total of 6,430 peptides (5,985 from cone snails and 445 from other venomous species) were used to evaluate model prediction capability. The proposed model achieved ideal accuracy (90.48%) in peptide therapeutic classification. Subsequent model outputs underwent further structural and binding pattern analysis against known targets, revealing significant similarities between the binding patterns of approved and novel peptides. The model's performance could be further enhanced by incorporating additional datasets and optimizing feature selection, potentially broadening its applicability to larger peptide datasets. Overall, this study underscores the potential of ML in advancing pharmacological research on diverse venom peptides.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.